Azacitidine and venetoclax in previously untreated
,2020年11月19日 — To the Editor: The activity of venetoclax in patients with acute ... Azacitidine and Venetoclax in Previously Untreated Acute Myeloid ... ,由 CD DiNardo 著作 · 2020 · 被引用 412 次 — In previously untreated patients who were ineligible for intensive chemotherapy, overall survival was longer and the incidence of remission ... ,2021年10月23日 — Request PDF | Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia | Background Older patients with acute myeloid ... ,2020年8月18日 — In VIALE-A clinical trial, previously untreated patients with acute myeloid leukaemia (AML) who were ineligible for intensive chemotherapy ... ,由 CD DiNardo 著作 · 2020 · 被引用 412 次 — Azacitidine and Venetoclax in Previously Untreated. Acute Myeloid Leukemia. C.D. DiNardo, B.A. Jonas, V. Pullarkat, M.J. Thirman, ... ,由 KK Patel 著作 · 2021 · 被引用 3 次 — These data suggest that use of azacitidine-venetoclax for previously untreated AML patients who are ineligible for intensive chemotherapy is ...
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 Azacitidine and venetoclax in previously untreated 相關參考資料
Azacitidine and Venetoclax in Previously Untreated Acute ...
https://www.nejm.org Azacitidine and Venetoclax in AML | NEJM
2020年11月19日 — To the Editor: The activity of venetoclax in patients with acute ... Azacitidine and Venetoclax in Previously Untreated Acute Myeloid ... https://www.nejm.org Azacitidine and Venetoclax in Previously Untreated ... - PubMed
由 CD DiNardo 著作 · 2020 · 被引用 412 次 — In previously untreated patients who were ineligible for intensive chemotherapy, overall survival was longer and the incidence of remission ... https://pubmed.ncbi.nlm.nih.go Azacitidine and Venetoclax in Previously ... - ResearchGate
2021年10月23日 — Request PDF | Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia | Background Older patients with acute myeloid ... https://www.researchgate.net Combination of Azacitidine and Venetoclax in Previously ...
2020年8月18日 — In VIALE-A clinical trial, previously untreated patients with acute myeloid leukaemia (AML) who were ineligible for intensive chemotherapy ... https://www.esmo.org Azacitidine and Venetoclax in Previously ... - Legeforeningen
由 CD DiNardo 著作 · 2020 · 被引用 412 次 — Azacitidine and Venetoclax in Previously Untreated. Acute Myeloid Leukemia. C.D. DiNardo, B.A. Jonas, V. Pullarkat, M.J. Thirman, ... https://www.legeforeningen.no Cost-effectiveness of azacitidine and venetoclax in unfit ...
由 KK Patel 著作 · 2021 · 被引用 3 次 — These data suggest that use of azacitidine-venetoclax for previously untreated AML patients who are ineligible for intensive chemotherapy is ... https://ashpublications.org |